A detailed history of C M Bidwell & Associates LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 4,530 shares of BSX stock, worth $465,185. This represents 0.22% of its overall portfolio holdings.

Number of Shares
4,530
Previous 4,726 4.15%
Holding current value
$465,185
Previous $507,000 12.82%
% of portfolio
0.22%
Previous 0.27%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$97.03 - $108.14 $19,017 - $21,195
-196 Reduced 4.15%
4,530 $442,000
Q2 2025

Aug 14, 2025

SELL
$89.7 - $107.41 $11,212 - $13,426
-125 Reduced 2.58%
4,726 $507,000
Q1 2025

May 14, 2025

BUY
$89.38 - $106.18 $257,414 - $305,798
2,880 Added 146.12%
4,851 $489,000
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $143,804 - $165,564
1,971 New
1,971 $165,000
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $3,202 - $5,668
-124 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$40.31 - $43.45 $4,998 - $5,387
124 New
124 $5,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.